Dr. Peter Attia is growing his footprint in the multi-billion-dollar longevity market.
This month, the longevity enthusiast announced that his Silicon Valley-based company, Biograph, has officially launched publicly and will open a second location in New York City this quarter. Alongside CEO and cofounder John Hering, who has reportedly donated large sums to Elon Musk’s startups per the Wall Street Journal, Attia is increasing his presence in the preventive health market for those looking to extend their lives. The market is a ripe place for Silicon Valley elites who are flocking to learn the lessons of living longer. “Think of it as the most advanced executive physical in the world focused on optimizing healthspan and lifespan,” the Biograph’s website reads, appealing to the success-focused leaders who have an eye on protecting more than their business ventures.
A surgeon by training, Attia is apt to deliver the lessons of “medicine 3.0” and the secrets to healthy aging. He shares these insights in his #1 New York Times Bestseller, Outlive: The Science and Art of Longevity, and advocates for precision medicine, rigorously testing the body to deliver personalized prevention and treatment plans so people can optimize their health.
His latest endeavor Biograph, which is operated by a team of medical doctors, analyzes over 1,000 data points over the course of over 20 evaluations, including a six-hour initial health testing visit, to deliver personalized health insights and risk assessments to members who pay $7,500 annually. Tests include grip strength, continuous glucose monitoring, at-home sleep apnea tests, a full-body MRI, and more. Those who opt for the $15,000 per year “Black” membership will receive expert guidance from the platform’s slew of nutrition and exercise consultants and ongoing monitoring, according to the website.
Extreme body tracking is a growing trend, attracting investors and the public alike. “I think people are moving further away from general wellness and more into trackable biohacking wellness as a general category, so people know and can see results and track their progress,” Brystal Rosensweig, a fractional CMO for wellness and beauty brands, told Fortune at longevity event last month, which was anchored by arguably the most controversial figure in the landscape, Bryan Johnson.
Read more from Fortune
“Diagnostics are foundational to evaluating and implementing an effective health strategy informed by a systems-based approach, as well as comprehensive analyses that consider each data point within the context of an individual’s entire health picture,” Attia says in a statement on the company’s website. In a 2023 interview with Oprah, Attia admits there is still no “silver bullet” to living longer, but believes there are ways each person can improve their aging trajectory. In stealth mode, the company claims over 15% of customers reported finding “urgent or life-altering health insights” from their data.
The advice on whether more data is beneficial is mixed. For example, the American Academy of Radiology does not recommend full-body MRIs because, according to a 2023 statement, “there is no documented evidence that total body screening is cost-efficient or effective in prolonging life. ” But that hasn’t stopped companies like Attia’s from jumping on the bandwagon to appeal to those willing to pay for more data.
TechCrunch reported that Biograph received backing from angel investor Balaji Srinivasan and Vy Capital, Human Capital, Alpha Wave, and WndrCo.
For more on the longevity market:
- Behind the scenes of this tech millionaire’s ‘Don’t Die’ summit as extreme biohacking becomes a dominant wellness trend
- Actress Halle Berry is ready for her ‘second act,’ as she becomes a major player in the $17 billion menopause market
- 5 ways to reduce your dementia risk as study estimates U.S. cases could double by 2060
